BMS-214662
BMS-214662 is a potent and selective farnesyltransferase inhibitor investigated for its antitumor properties. It has been utilized in preclinical in vitro and in vivo studies targeting cancers such as pancreatic, lung, and head and neck malignancies.
Product Specifications
CAS Number
195987-41-8
Field of Research
Metabolism Research, Signal Transduction
Purity
99.58% (May vary between batches)
Smiles
C ([C@H]1N (S (=O) (=O) C2=CC=CS2) CC=3C (N (CC4=CN=CN4) C1) =CC=C (C#N) C3) C5=CC=CC=C5
Molecular Formula
C25H23N5O2S2
Molecular Weight
489.61
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC882198-500 1x 500 µL
NKX2.2 (Neuroendocrine & Ewing's Sarcoma Marker) (NX2/2198R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471042-500 1x 500 µL
TRIM29 (TRIM29/1042), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681930-100 1x 100 µL
PAX5 / BSAP (Early B-Cell Marker) (PCRP-PAX5-1B1), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400972-100 1x 100 µL
Myeloid-Associated Differentiation Marker (MYADM/972), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 